Tori B Terrell-Hall
Overview
Explore the profile of Tori B Terrell-Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohammad A, Griffith J, Adkins C, Shah N, Sechrest E, Dolan E, et al.
Pharm Res
. 2018 Jan;
35(2):31.
PMID: 29368289
Purpose: The blood-tumor barrier (BTB) limits irinotecan distribution in tumors of the central nervous system. However, given that the BTB has increased passive permeability we hypothesize that liposomal irinotecan would...
2.
Terrell-Hall T, Nounou M, El-Amrawy F, Griffith J, Lockman P
Oncotarget
. 2017 Nov;
8(48):83734-83744.
PMID: 29137378
Background: Drug and antibody delivery to brain metastases has been highly debated in the literature. The blood-tumor barrier (BTB) is more permeable than the blood-brain barrier (BBB), and has shown...
3.
Terrell-Hall T, Ammer A, Griffith J, Lockman P
Fluids Barriers CNS
. 2017 Jan;
14(1):3.
PMID: 28114946
Background: The lack of translatable in vitro blood-tumor barrier (BTB) models creates challenges in the development of drugs to treat tumors of the CNS and our understanding of how the...
4.
Nounou M, Adkins C, Rubinchik E, Terrell-Hall T, Afroz M, Vitalis T, et al.
Pharm Res
. 2016 Aug;
33(12):2930-2942.
PMID: 27528392
Purpose: The ability of human melanotransferrin (hMTf) to carry a therapeutic concentration of trastuzumab (BTA) in the brain after conjugation (in the form of trastuzumab-melanotransferrin conjugate, BT2111 conjugate) was investigated...
5.
Bohn K, Adkins C, Mittapalli R, Terrell-Hall T, Mohammad A, Shah N, et al.
J Neurosci Methods
. 2016 Jun;
270:124-131.
PMID: 27321229
Background: Measurement of vascular density has significant value in characterizing healthy and diseased tissue, particularly in brain where vascular density varies among regions. Further, an understanding of brain vessel size...
6.
Adkins C, Mohammad A, Terrell-Hall T, Dolan E, Shah N, Sechrest E, et al.
Clin Exp Metastasis
. 2016 Mar;
33(4):373-83.
PMID: 26944053
The blood-brain barrier (BBB) is compromised in brain metastases, allowing for enhanced drug permeation into brain. The extent and heterogeneity of BBB permeability in metastatic lesions is important when considering...
7.
Adkins C, Nounou M, Mittapalli R, Terrell-Hall T, Mohammad A, Jagannathan R, et al.
Cancer Prev Res (Phila)
. 2014 Oct;
8(1):68-76.
PMID: 25348853
The observation that approximately 15% of women with disseminated breast cancer will develop symptomatic brain metastases combined with treatment guidelines discouraging single-agent chemotherapeutic strategies facilitates the desire for novel strategies...